The Oncologist
Volume 9, Supplement 4, 2004

Optimizing Bisphosphonate Therapy in Oncology

This supplement was made possible by an unrestricted educational grant from Novartis Pharmaceuticals Corporation.

Click here to go to the supplement Table of Contents